Skip to main content
SpringerLink
Log in

Relationship between ERBB2 and E-cadherin expression in human breast cancer

  • Original Article
  • Published:
Virchows Archiv Aims and scope Submit manuscript

Abstract

A recent in vitro study has suggested that overexpression of ERBB2 may mediate breast tumour progression and metastasis by inhibiting the transcription of the E-cadherin (E-CD) gene. To test this hypothesis in human breast cancer in vivo, we studied the relationship between the expression of both molecules in 247 breast carcinomas immunohistochemically. Five ductal carcinomas in situ overexpressed ERBB2 and showed preserved E-CD expression. Forty-four of 226 infiltrating ductal carcinomas (19.47%) showed ERBB2 overexpression, and a statistically significant relationship was found between ERBB2 overexpression and high histological grade. E-CD expression was preserved in 111 cases (49.1%) and correlated with the histological grade. However, no significant relationship was found between ERBB2 and E-CD expression. None of the 16 infiltrating lobular carcinomas expressed ERBB2 or E-CD. These observations in different histological types of breast carcinoma strongly argue against a role for ERBB2 as a transcriptional regulator of E-CD expression in most human breast carcinomas in vivo.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bartkova J, Barnes DM, Millis RR, Gullick WJ (1990) Immunohistochemical demonstration of c-erbB-2 in mammary ductal carcinoma in situ. Hum Pathol 21:1164–1167

    Google Scholar 

  2. Behrens J, Vakaet L, Friis R, Vinterhager E, Van Roy F, Mareel MM, Birchmeier W (1993) Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/β-catenin complex in cells transformed with a temperature-sensitive v-SRC gene. J Cell Biol 120:757–766

    Google Scholar 

  3. Birchmeier W, Behrens J (1994) Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim Biophys Acta 1198:11–26

    Google Scholar 

  4. Ciocca DR, Fujimura FK, Tandon AK, Clark GM, Mark C, Lee-Chen GJ, Pounds GW, Vendely P, Owens MA, Pandian MR, McGuire WL (1992) Correlation of HER-2/neu amplification with expression and with other prognostic factors in 1103 breast caners. J Natl Cancer Inst 84:1279–1282

    Google Scholar 

  5. D'souza B, Taylor-Papadimitriou J (1994) Overexpression of ERBB2 in human mammary epithelial cells signals inhibition of transcription of the E-CD gene. Proc Natl Acad Sci USA 91:7202–7206

    Google Scholar 

  6. Dorudi S, Sheffield JP, Poulsom R, Northover JMA, Hart IR (1993) E-cadherin expression in colorectal cancer. An immunocytochemical and in situ hybridization study. Am J Pathol 142:981–986

    Google Scholar 

  7. Elston CW (1987) Grading of invasive carcinoma of the breast. In: Page DL, Anderson TJ (eds) Diagnostic histopathology of the breast. Churchill Livingston, Edinburgh, pp 300–311

    Google Scholar 

  8. Gamallo C, Palacios J, Suárez A, Pizarro A, Quintanilla M, Cano A (1993) Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. Am J Pathol 142:987–993

    Google Scholar 

  9. Gusterson BA, Gelber RD, Goldhirsch A et al (1992) Prognostic importance of c-erbB-2 expression in breast cancer. J Clin Oncol 10:1049–1056

    Google Scholar 

  10. Hoskin K, Weber B (1994) The biology of breast cancer. Curr Opin Oncol 6:554–559

    Google Scholar 

  11. Kerns BM, Jordan PA, Huper G, Marks JR, Iglejart D, Layfield LJ (1993) Assessment of c-erbB-2 by immunohistochemistry in paraffin-embedded breast cancer. Mod Pathol 6:673–678

    Google Scholar 

  12. Lagios MD, Margolin FR, Westdahl PR, Rose MR (1989) Mammographically detected ductal carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade in local recurrence. Cancer 63:618–624

    Google Scholar 

  13. Lipponen P, Saarelainen E, Ji H, Aaltomaa A, Syrjänen K (1994) Expression of E-cadherin (E-CD) as related to other prognostic factors and survival in breast cancer. J Pathol (Lond) 174:101–109

    Google Scholar 

  14. Lupu R, Lippman ME (1993) The role of erbB2 signal transduction pathways in human breast cancer. Breast Cancer Res Treat 27:83–93

    Google Scholar 

  15. Mareel M, Bracke M, VanRoy F (1994) Invasion promoter versus invasion suppressor molecules: the paradigm of E-cadherin. Mol Biol Rep 19:45–67

    Google Scholar 

  16. Moll R, Mitze M, Frixen UW, Birchmeier W (1993) Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Am J Pathol 143:1731–1742

    Google Scholar 

  17. Muthuswamy SK, Siegel PM, Dankort DL, Webster MA, Muller WJ (1994) Mammary tumors expressing the neu protooncogene possess elevated c-Src tyrosine kinase activity. Mol Cell Biol 14:735–743

    Google Scholar 

  18. Navarro P, Gómez M, Pizarro A, Gamallo C, Quintanilla M, Cano A (1991) A role for the E-cadherin cell-cell adhesion molecule during tumor progression of mouse epidermal carcinogenesis. J Cell Biol 115:517–533

    Google Scholar 

  19. Ochiai A, Akimoto S, Kanai Y, Shibata T, Oyama T, Hirohashi S (1994) c-erbB-2 gene product associates with catenins in human cancer cells. Biochem Biophys Res Commun 205:73–78

    Google Scholar 

  20. Oka H, Shiozaki H, Kobayashi K, Inoue M, Yahara H, Kobayashi T, Takatsuka Y, Matsuyoshi N, Hirano S, Takeichi M, Mori T (1993) Expression of E-CD cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res 53:1696–1701

    Google Scholar 

  21. Palacios J, Benito N, Pizarro A, Suárez A, Espada J, Cano A, Gamallo C (1995) Anomalous expression of P-cadherin in breast carcinoma. Correlation with E-cadherin expression and pathological features. Am J Pathol 146:605–612

    Google Scholar 

  22. Paterson MC, Dietrich KD, Danyluk J, Paterson AHG, Lees AW, Jamil N, Hanson J, Jenkins H, Krause BE, McBlain WA, Slamon DJ, Fourney RM (1991) Correlation between c-erbB-2 amplification and risk of recurrent disease in node negative breast cancer. Cancer Res 51:556–567

    Google Scholar 

  23. Pizarro A, Benito N, Navarro P, Palacios J, Cano A, Quintanilla M, Contreras F, Gamallo C (1994) E-cadherin expression in basal cell carcinoma. Br J Cancer 69:157–162

    Google Scholar 

  24. Rasbridge SA, Gillett CE, Sampson SA, Walsh FS, Millis RR (1993) Epithelial (E-) and placental (P-) cadherin cell adhesion molecule expression in breast carcinoma. J Pathol (Lond) 169:245–250

    Google Scholar 

  25. Schechter AL, Hung MC, Vaidyanathans L, Weinberg RA, Yang-Feng TL, Franke U, Ullrich A, Coussens L (1985) The neu gene: an erb-B-homologous gene distinct from and unlinked to the gene encoding the EGF receptor. Science 229:976–978

    Google Scholar 

  26. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235:177–182

    Google Scholar 

  27. Takeichi M (1991) Cadherin cell adhesion receptors as a morphogenetic regulator. Science 251:1451–1455

    Google Scholar 

  28. Toikkanen S, Helin H, Isola J, Joensuu H (1992) Prognostic significance of HER-2 oncoprotein expression in breast cancer: a 30-year follow-up. J Clin Oncol 10:1044–1048

    Google Scholar 

  29. Tsuda H, Hirohashi S, Shimoshato Y, Hirota T, Tsugane S, Watanabe S, Terada M, Yamamoto H (1990) Correlation between histologic grade of malignancy and copy number of c-erbB-2 gene in breast cancer. A retrospective analysis of 176 cases. Cancer 65:1794–1800

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departamento de Anatomía Patológica, Hospital La Paz, Paseo de la Castellana 261, E-28046, Madrid, Spain

    J. Palacios, N. Benito, A. Pizarro, M. A. Limeres, A. Suárez & C. Gamallo

  2. Instituto de Investigaciones Biomédicas, Consejo Superior de Investigaciones Científicas, Departamento de Bioquímica, Faculdad de Medicina, Universidad Autónoma, Madrid, Spain

    A. Cano

Authors
  1. J. Palacios
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N. Benito
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Pizarro
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. A. Limeres
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. Suárez
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. C. Gamallo
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. A. Cano
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Palacios, J., Benito, N., Pizarro, A. et al. Relationship between ERBB2 and E-cadherin expression in human breast cancer. Vichows Archiv A Pathol Anat 427, 259–263 (1995). https://doi.org/10.1007/BF00203392

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00203392

Key words

Search

Navigation